| P50 | author | Theodoros Eleftheriadis | Q48170796 |
| | Georgios Pissas | Q61090594 |
| P2093 | author name string | Vassilios Liakopoulos | |
| | Georgia Antoniadi | |
| | Maria Sounidaki | |
| | Christos Rountas | |
| | Loannis Stefanidis | |
| P2860 | cites work | Dioxins and cardiovascular disease mortality | Q23918980 |
| | The AMPK signalling pathway coordinates cell growth, autophagy and metabolism | Q24616273 |
| | Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR | Q27001717 |
| | An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor | Q28249782 |
| | Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site | Q28363492 |
| | A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 |
| | The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease | Q28382992 |
| | FGF21 is an endocrine signal of protein restriction | Q28572009 |
| | Activation of general control nonderepressible 2 kinase protects human glomerular endothelial cells from harmful high-glucose-induced molecular pathways | Q46510122 |
| | 3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells | Q46771705 |
| | Twenty-four–hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction | Q48324713 |
| | Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. | Q50993162 |
| | Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells. | Q51463159 |
| | Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. | Q51512645 |
| | Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study. | Q51762707 |
| | Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells. | Q52870199 |
| | Differential effects of the two amino acid sensing systems, the GCN2 kinase and the mTOR complex 1, on primary human alloreactive CD4⁺ T-cells. | Q53132210 |
| | Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation. | Q53591463 |
| | Low serum tryptophan predicts higher mortality in cardiovascular disease. | Q53638477 |
| | Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation. | Q54334801 |
| | Neopterin and kynurenine–tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study | Q59275980 |
| | Purification and assay of carnitine acyltransferases | Q69497362 |
| | Rapid transport of biologically intact insulin through cultured endothelial cells | Q70324919 |
| | An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium | Q72068963 |
| | p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions | Q81402289 |
| | Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease | Q82137133 |
| | Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL | Q82260520 |
| | p53 Levels positively correlate with carotid intima-media thickness in patients with subclinical atherosclerosis | Q82311334 |
| | Association of metabolic syndrome with reduced central serotonergic activity | Q83012491 |
| | Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation | Q86044641 |
| | The pathobiology of diabetic complications: a unifying mechanism | Q29617766 |
| | mTOR signaling at a glance | Q29619857 |
| | Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor | Q33236675 |
| | The clinical epidemiology of cardiac disease in chronic renal failure | Q33686744 |
| | Insulin assays and reference values | Q33816598 |
| | Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats | Q33857313 |
| | An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells | Q34187909 |
| | Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 |
| | Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation | Q34435166 |
| | Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement | Q34715391 |
| | Atherosclerosis and cancer: common pathways on the vascular endothelium. | Q34990177 |
| | Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome | Q34998494 |
| | Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice. | Q35573469 |
| | Dual role of methionyl-tRNA synthetase in the regulation of translation and tumor suppressor activity of aminoacyl-tRNA synthetase-interacting multifunctional protein-3 | Q35621172 |
| | Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development | Q36207412 |
| | Monitoring tryptophan metabolism in chronic immune activation | Q36247653 |
| | Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 |
| | Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease | Q36325036 |
| | The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease | Q36380101 |
| | Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model | Q36678362 |
| | Molecules in focus: indoleamine 2,3-dioxygenase. | Q36744423 |
| | Endothelial function and dysfunction: testing and clinical relevance | Q36758044 |
| | Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice | Q37096324 |
| | Metabolic syndrome in rheumatological diseases. | Q37377015 |
| | Myocardial fatty acid metabolism in health and disease | Q37677921 |
| | Factors determining insulin resistance in chronic hemodialysis patients | Q37882289 |
| | Insulin resistance and cancer: epidemiological evidence | Q38031219 |
| | Keeping the eIF2 alpha kinase Gcn2 in check | Q38204568 |
| | Activation of p53 in Human and Murine Cells by DNA-Damaging Agents Differentially Regulates Aryl Hydrocarbon Receptor Levels | Q38886662 |
| | Nutritional Status is Associated with Inflammation and Predicts a Poor Outcome in Patients with Chronic Heart Failure | Q38919038 |
| | Aryl hydrocarbon receptor (AhR) attenuation of subchronic cigarette smoke-induced pulmonary neutrophilia is associated with retention of nuclear RelB and suppression of intercellular adhesion molecule-1 (ICAM-1). | Q39002303 |
| | Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris | Q39071200 |
| | Association Between Protein Intake and Mortality in Hypertensive Patients Without Chronic Kidney Disease in the OLD-HTA Cohort. | Q39840827 |
| | Hemodynamic actions of insulin | Q40696222 |
| | Type III cyclic nucleotide phosphodiesterases and insulin action | Q40996507 |
| | Multiple signaling pathways involved in the metabolic effects of insulin | Q41592332 |
| | Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study | Q43235071 |
| | Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study | Q44043328 |
| | GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. | Q46490849 |
| P433 | issue | 1-2 | |
| P921 | main subject | fatty acid | Q61476 |
| | reactive oxygen species | Q424361 |
| | insulin resistance | Q1053470 |
| P304 | page(s) | 41-56 | |
| P577 | publication date | 2017-02-04 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways | |
| P478 | volume | 428 | |